The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Mainolfi Nello

Reporting owner CIK 0001821189 · Chief Executive Officer · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Mainolfi NelloMainolfi NelloMainolfi Nello · October 1, 2026 · Exercise / conversion · Common StockMainolfi Nello · December 31, 2025 · Exercise / conversion · Common StockMainolfi Nello · December 17, 2025 · Exercise / conversion · Common StockMainolfi Nello · December 8, 2025 · Exercise / conversion · Common StockMainolfi Nello · October 29, 2025 · Exercise / conversion · Common StockOct 29, 2025Oct 1, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 1, 2026Kymera Therapeutics, Inc.Common StockMainolfi NelloExercise / conversion
Dec 31, 2025Kymera Therapeutics, Inc.Common StockMainolfi NelloExercise / conversion
Dec 17, 2025Kymera Therapeutics, Inc.Common StockMainolfi NelloExercise / conversion
Dec 8, 2025Kymera Therapeutics, Inc.Common StockMainolfi NelloExercise / conversion
Oct 29, 2025Kymera Therapeutics, Inc.Common StockMainolfi NelloExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Kymera Therapeutics, Inc.KYMR · company listings
Mainolfi NelloChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M30,0002.08Value: 62,400Currency not specifiedView ↗
Trade: Kymera Therapeutics, Inc.KYMR · company listings
Mainolfi NelloChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M30,0002.08Value: 62,400Currency not specifiedView ↗
Trade: Kymera Therapeutics, Inc.KYMR · company listings
Mainolfi NelloChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M2,59538.53Value: 99,985.35Currency not specifiedView ↗
Trade: Kymera Therapeutics, Inc.KYMR · company listings
Mainolfi NelloChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M100,0002.08Value: 208,000Currency not specifiedView ↗
Trade: Kymera Therapeutics, Inc.KYMR · company listings
Mainolfi NelloChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M30,0002.08Value: 62,400Currency not specifiedView ↗